Market capitalization | $6.11b |
Enterprise Value | $6.41b |
P/E (TTM) P/E ratio | 51.40 |
EV/FCF (TTM) EV/FCF | 36.52 |
EV/Sales (TTM) EV/Sales | 4.84 |
P/S ratio (TTM) P/S ratio | 4.62 |
P/B ratio (TTM) P/B ratio | 4.62 |
Revenue growth (TTM) Revenue growth | 8.35% |
Revenue (TTM) Revenue | $1.32b |
As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.
12 Analysts have issued a Merit Medical Systems, Inc. forecast:
12 Analysts have issued a Merit Medical Systems, Inc. forecast:
Sep '24 |
+/-
%
|
||
Revenue | 1,323 1,323 |
8%
8%
|
|
Gross Profit | 603 603 |
16%
16%
|
|
EBITDA | 266 266 |
22%
22%
|
EBIT (Operating Income) EBIT | 156 156 |
31%
31%
|
Net Profit | 120 120 |
20%
20%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Merit Medical Systems, Inc. engages in the manufacture and marketing of proprietary disposable medical devices. It operates through the Cardiovascular and Endoscopy segments. The Cardiovascular segment consists of peripheral intervention, cardiac intervention, interventional oncology and spine, and cardiovascular and critical care product groups. The Endoscopy segment integrates non-vascular stent technology with balloon dilators, inflation devices, guide wires, procedure kits, and other devices that are used by gastroenterologists, endoscopists, pulmonologists, and thoracic and general surgeons. The company was founded by Fred P. Lampropoulos, Darla Gill, Kent W. Stanger, and William Padilla in July 1987 and is headquartered in South Jordan, UT.
Head office | United States |
CEO | Fred Lampropoulos |
Employees | 6,950 |
Founded | 1987 |
Website | www.merit.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.